UnknownNot Applicable

Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner

Belgium30 participantsStarted 2021-02-02

Plain-language summary

To assess the added value of magnetic resonance imaging (MRI) of the skeleton compared to other validated techniques for the detection of bone lesions in patients with multiple myeloma.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with newly diagnosed multiple myeloma, for whom bone imaging is required for staging. * Recurrent patient after intensive treatment (high dose chemotherapy, bone marrow transplant, etc.). * Patient requiring a PET / CT considered as the technique of choice in these stages of the disease. Exclusion Criteria: * Implanted material incompatible with MRI. * Severe claustrophobia. * Pregnant women

What they're measuring

Evaluation of the diagnostic performance of the different imaging protocols

Timeframe: through study completion, an average of 1 year

Comparison of Sensitivity (Se) and Predictive Precision (Acc) of the different imaging protocols

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT05381077

SponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-31

Contact for this trial

Frederic Lecouvet, MD-PhD

+3227642793 frederic.lecouvet@uclouvain.be

View on ClinicalTrials.gov More Multiple Myeloma trials